APOA2 and metabolic dysfunction-associated steatotic liver disease: For example, we observed that genes involved in lipid and FFA metabolism, such as APOC1, APOA2, PPARA, and FADS2, were down-regulated in both treated HepG2 cells and NAFLD livers (Figure S3A–D).